STSS vs. TNON, INVO, QNRX, IONM, VERO, GMVDF, TMDIF, AEMD, RSLS, and DYNT
Should you be buying Sharps Technology stock or one of its competitors? The main competitors of Sharps Technology include Tenon Medical (TNON), INVO Bioscience (INVO), Quoin Pharmaceuticals (QNRX), Assure (IONM), Venus Concept (VERO), G Medical Innovations (GMVDF), Titan Medical (TMDIF), Aethlon Medical (AEMD), ReShape Lifesciences (RSLS), and Dynatronics (DYNT). These companies are all part of the "surgical & medical instruments" industry.
Tenon Medical (NASDAQ:TNON) and Sharps Technology (NASDAQ:STSS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, media sentiment, dividends, earnings, institutional ownership, community ranking and risk.
Sharps Technology has a net margin of 0.00% compared to Sharps Technology's net margin of -445.77%. Tenon Medical's return on equity of -102.25% beat Sharps Technology's return on equity.
Tenon Medical currently has a consensus target price of $3.00, suggesting a potential upside of 285.11%. Given Sharps Technology's higher probable upside, analysts plainly believe Tenon Medical is more favorable than Sharps Technology.
Sharps Technology has lower revenue, but higher earnings than Tenon Medical.
In the previous week, Tenon Medical had 6 more articles in the media than Sharps Technology. MarketBeat recorded 7 mentions for Tenon Medical and 1 mentions for Sharps Technology. Tenon Medical's average media sentiment score of 1.11 beat Sharps Technology's score of 0.14 indicating that Sharps Technology is being referred to more favorably in the news media.
22.7% of Tenon Medical shares are owned by institutional investors. Comparatively, 17.2% of Sharps Technology shares are owned by institutional investors. 8.4% of Tenon Medical shares are owned by insiders. Comparatively, 14.1% of Sharps Technology shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Tenon Medical received 2 more outperform votes than Sharps Technology when rated by MarketBeat users.
Tenon Medical has a beta of 2.21, indicating that its share price is 121% more volatile than the S&P 500. Comparatively, Sharps Technology has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500.
Summary
Tenon Medical beats Sharps Technology on 7 of the 13 factors compared between the two stocks.
Get Sharps Technology News Delivered to You Automatically
Sign up to receive the latest news and ratings for STSS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding STSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sharps Technology Competitors List
Related Companies and Tools
